What was Memphis Pharmaceuticals's net profit in 2026?

Memphis Pharmaceuticals's net profit in 2026 was 480 million EGP, down 5.0% from 505 million EGP in 2025. Source: annual statements 2026.

What were Memphis Pharmaceuticals's total assets and shareholders' equity in 2026?

Total assets at the end of 2026 were 1.49 billion EGP, and shareholders' equity 843 million EGP. Source: annual statements 2026.

Was Memphis Pharmaceuticals's operating cash flow positive in 2026?

Operating cash flow in 2026 was positive at 220 million EGP. Source: annual statements 2026.

EGX·Health Care & Pharmaceuticals

Memphis Pharmaceuticals

MPCI

Fiscal year starts in July · currency EGP · latest: Annual 2026

Next results: Q1 2027 — expected around 8 December 2026estimated from earlier disclosure datesResults calendar ←

311.65EGP+3.89% today1w +13.3%1m −14.6%delayed · 3 November

Net profit · 2026

480million

▼ 5.0% vs 2025

Total assets · 2026

1.49billion

▼ 0.2% vs 2025

Shareholders' equity · 2026

843million

▲ 9.4% vs 2025

Operating cash flow · 2026

220million

▲ 153.5% vs 2025

Key facts

Source: annual statements 2026

Memphis Pharmaceuticals's net profit in 2026 was 480 million EGP, down 5.0% from 505 million EGP in 2025.
Total assets at the end of 2026 were 1.49 billion EGP, and shareholders' equity 843 million EGP.
Operating cash flow in 2026 was positive at 220 million EGP.

Memphis Pharmaceuticals's Q1 2027 results are expected around 8 December — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Ask about Memphis Pharmaceuticals

How much did Memphis Pharmaceuticals's net profit grow last year?What were total assets and shareholders' equity in the latest annual balance sheet?Was operating cash flow positive in the last three years?Type your question…Ask

3 free questions a day after signing up. With Google, no password.

Annual net profit last 6 years

Net profit

41.81million

74.09million

90.44million

191million

505million

480million

202120222023202420252026

Summarised financial statements

Excel · Pro

Swipe the table to see the other years.

Item · EGP202120222023202420252026

Income statement

Net profit41.81 million74.09 million90.44 million191 million505 million480 million

Gross profit174 million157 million217 million71.88 million684 million707 million

Total assets432 million560 million786 million1.22 billion1.49 billion1.49 billion

Total liabilities470 million524 million681 million1.07 billion722 million647 million

Shareholders' equity-38.18 million36.64 million105 million149 million771 million843 million

Total liabilities and equity432 million560 million786 million1.22 billion1.49 billion1.49 billion

Operating cash flow3.47 million-22.01 million57.94 million183 million86.89 million220 million

Investing cash flow2.62 million-5.24 million-582 thousand30.59 million29.71 million63.35 million

Financing cash flow-250 thousand—2.34 million163 million-39.21 million-351 million

Net change in cash5.84 million-25.38 million59.7 million376 million159 million-67.24 million

With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Memphis Pharmaceuticals

Key facts

Memphis Pharmaceuticals's Q1 2027 results are expected around 8 December — we email you the day they land

Summarised financial statements

Results by period

Financial reports (19)

Other companies in Health Care & Pharmaceuticals